A comprehensive understanding of the key cellular functions of PALB2 and the disruption of these functions in mutation carrier individuals, may eventually provide new clues and means for developing more effective ways of cancer therapy, based on the underlying specific cancer predisposing germline gene defect. This evidence concerns the gene PALB2 and cancer.